| Previous close | 12.31 |
| Open | 8.76 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 825.00 |
| Expiry date | 2024-08-09 |
| Day's range | 8.76 - 12.35 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Investor's Business DailyStock Market: S&P 500, Nasdaq Hit Highs As Tesla Soars, Rate-Cut Hopes Rise: Weekly Review
Tesla drove the S&P 500 and Nasdaq to highs, though small caps fell for the week. Cooling economic data raised rate-cut hopes.
ZacksPharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Eli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi (SNY) and Regeneron's Dupixent gets approval for COPD in Europe.
FX EmpireEli Lilly Remains an Equities Outlier
New obesity and Alzheimer’s disease treatments are keeping Eli Lilly and Company (LLY) at the forefront of equities excellence.
© 2024 Yahoo. All rights reserved.